Effects of non-depolarizing neuromuscular blocking agents on norepinephrine release from human atrial tissue obtained during cardiac surgery

British Journal of Anaesthesia

Volumn 82, Issue 6, 1999, Pages 904-909

  Sato, K ^a   Windisch, K ^a   Matko, I ^b   Vizi, E S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Heart, heart rate; Neuromuscular block; Surgery, cardiovascular; Sympathetic nervous system, norepinephrine

Indexed keywords

GALLAMINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROMUSCULAR BLOCKING AGENT; NORADRENALIN; PANCURONIUM; ROCURONIUM; TRITIUM;

ARTICLE; CLINICAL ARTICLE; HEART ATRIUM; HEART RATE; HEART SURGERY; HUMAN; HUMAN TISSUE; NERVE ENDING; PRIORITY JOURNAL; SYMPATHETIC NERVE; TACHYCARDIA;

EID: 0033027287     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/82.6.904     Document Type: Article

References (29)

1. Muscholl E. Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 1980; 239: H713-20
2. Kobayashi O, Nagashima H, Duncalf D, et al. Direct evidence that pancuronium and gallamine enhance the release of norepinephrine from the atrial sympathetic nerve by inhibiting prejunctional muscarinic receptors. J Auton Nerv Syst 1981; 18: 55-60
3. Foldes FF, Kobayashi O, Kinjo M, et al. Presynaptic effect of muscle relaxants on the release of 3H-norepinephine controlled by endogenous acetylcholine in guinea pig atrium. J Neural Transm 1989; 76: 169-80
4. Vizi ES. Effects other than relaxation of non-depolarizing muscle relaxants. In: Fukushima K, Ochai R, eds. Muscle Relaxants. Tokyo: Springer, 1995; 67-71
5. Vizi ES, Lendvai B. Side effect on non-depolarizing muscle relaxants: relationship to their antinicotinic and antimuscarinic actions. Pharmacol Ther 1997; 73: 75-89
6. Somogyi GT, Keast JR, Vizi ES. Modulation of the release of noradrenaline from electrically stimulated bicuspid valve leaflet of the rabbit heart. J Auton Nerv Syst 1991; 35: 99-106
7. Matkó I, Fehér E, Vizi ES. Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle. Cardiovasc Res 1994; 28: 700-4
8. Bowman WC. Pharmacology of Neuromuscular Function. Bristol: John Wright, 1990
9. Lien CA. Rational use of muscle relaxants. Anesth Analg 1994; 6: 66-72
10. Edwards RP, Miller RD, Roizen MF. Cardiac responses to imipramine and pancuronium during anesthesia with halothane or enflurane. Anesthesiology 1979; 50: 421-5
11. Clarke RSJ, Mirakhur RK. Adverse effect of muscle relaxants. Adverse Drug React Toxicol Rev 1994; 13: 23-41
12. Sear JW. Pharmacodynamics and pharmacokinetics of neuromuscular blocking drugs. In: Agoston S, Bowman WC, eds. Muscle Relaxants. Amsterdam: Elsevier, 1990; 457-80
13. Bevan DR. Muscle relaxants in elderly patients. In: Fukushima K, Ochiai R, eds. Muscle Relaxants. Tokyo: Springer, 1995; 224-30
14. Mccoy EP, Maddineni VR, Elliott P, Mirakhur RK, Carson IW, Cooper AR. Haemodynamic effects of rocuronium during fentanyl anaesthesia. Comparison with vecuronium. Can J Anaesth 1993; 40: 703-8
15. Lee Son S, Waud DR. Effects of non-depolarizing blocking agents on the cardiac vagus nerve in the guinea-pig. Br J Anaesth 1980; 52: 981-6
16. Lee Son S, Waud DR. A vagolytic action of neuromuscular blocking agents at the pacemaker of the isolated guinea-pig atrium. Anesthesiology 1948; 48: 191-4
17. Manabe N, Foldes FF, Torocsik A, Nagashima H, Goldiner PL, Vizi ES. Presynaptic interaction between vagal and sympathetic innervation in the heart: modulation of acetylcholine and noradrenaline release. J Auton Nerv Syst 1991; 32: 233-42
18. Conway CM, Salt PJ, Barnes PR. Inhibition of neuronal uptake of noradrenaline by pancuronium in the isolated perfused rat heart. Br J Anaesth 1979; 51: 66-8
19. 3H noradrenaline. Br J Anaesth 1989; 62: 683-91
20. Brown BR, Crout JR. The sympathomimetic effect of gallamine on the heart. J Pharm Exp Ther 1970; 266: 172
21. Hughers R, Chapple DJ. Effect of non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats. Br J Anaesth 1976; 48: 59-68
22. Salt PJ, Barnes PK, Conway CM. Inhibition of neuronal uptake of noradrenaline in the isolated perfused rat heart by pancuronium and its homologues, Org6368, Org7268 and Org NC 45. Br J Anaesth 1980; 52: 313
23. Miller RD, Eger EI II, Stevens WC, Gibbons R. Pancuronium induced tachycardia in relation to alveolar halothane, dose of pancuronium, and prior atropine. Anesthesiology 1975; 42: 352
24. Foldes FF, Nagashima H, Nguyen HD, Dancalf D, Goldiner PL. Neuromuscular and cardiovascular effects of pipecuronium. Can J Anaesth 1990; 37: 549-55
25. Tassonyi E, Neidhart P, Pittet JF, Morel DR, Gemperle M. Cardiovascular effects of pipecuronium and pancuronium in patients undergoing coronary artery bypass grafting. Anaesthesia 1988; 69: 793-6
26. Wierda JMKH, Karuczek GF, Vanderbroom RHG, et al. Pharmacokinetics and cardiovascular dynamics of pipecuronium bromide during coronary artery surgery. Can J Anaesth 1990; 37: 183-91
27. Wierda JMKH, van den Broek L, Proost JH, Verbaan BW, Hennis PJ. Time course of action of ORG9487: a new short acting steroidal muscle relaxant. Comparison with succinylcholine. Anesth Analg 1993; 77: 579-84
28. Münch G, Kurz T, Urlbauer T, Sayfarth M, Richardt G. Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia. Br J Pharmacol 1996; 118: 1855-61
29. Vizi ES, Somogyi GT, Nagashima H, et al. Tubocurarine and pancuronium inhibit evoked release of acetylcholine from the mouse hemidiaphragm preparation. Br J Anaesth 1987; 59: 226-31